Login / Signup

Baseline Characteristics and Patient-Reported Outcomes of ADPKD Patients in the Multicenter TAME-PKD Clinical Trial.

Stephen L SeligerTerry WatnickAndrew D AlthouseRonald D PerroneKaleab Z AbebeKenneth R HallowsDana C MiskulinKyongtae T Bae
Published in: Kidney360 (2022)
Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease (TAME), NCT02656017.
Keyphrases